drugset / Trial / NCT02587130

Ketamine and Refractory Painful Care in a Palliative Unit

NCT02587130 ↗

Phase 4 Terminated 8 enrolled Lille Catholic University
NaSingle-groupOpen-labelTreatment

Summary

Pain is one of the major symptoms in palliative care units and often is very difficult to treat, being considered as a refractory pain. There are different causes of refractory pain: pain due to bed sores and ulcer bandages, carcinological or ischemic wounds or injuries, pain due to patients' reduced mobility, pain due to traumatological injuries, pain associated with a long-term bed confinement, etc. The investigators propose a prospective study to estimate the effect and the tolerance to a subcutaneous bolus of ketamine administered for the treatment of refractory pain due to the care of bedsores, ulcers and vascular wounds in patients hospitalized in palliative care units.

Timeline

Start
2016-05
Primary completion
2019-01-10
Completion
2019-01-10

Outcome

Outcome not reported

Stopped (Enrollment): “difficulted recruiting”

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule — Subcutaneous

Indications